Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samy Hadjadj

Showing results (101-110 of 216) with videos related to

Pageof 22
Sort By:
Journal of the American Heart Association|February 27, 2018
Circulating Concentrations of Redox Biomarkers Do Not Improve the Prediction of Adverse Cardiovascular Events in Patients With Type 2 Diabetes MellitusMaxime Cournot, Elena Burillo, Pierre-Jean Saulnier, et al.
International Journal of Cardiology|May 8, 2012
Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortalityRonan Roussel, Samy Hadjadj, Blandine Pasquet, et al.
Diabetes & Metabolism|October 22, 2020
Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO studyBertrand Cariou, Thomas Goronflot, Antoine Rimbert, et al.
Diabetes, Obesity & Metabolism|September 2, 2022
Associations of microvascular complications with all-cause death in patients with diabetes and COVID-19: The CORONADO, ABCD COVID-19 UK national audit and AMERICADO study groupsSamy Hadjadj, Pierre-Jean Saulnier, Yue Ruan, et al.
Diabetologia|October 22, 2015
Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetesSamy Hadjadj, Bertrand Cariou, Frederic Fumeron, et al.
Journal of Hepatology|February 8, 2024
Primary hypocholesterolemia is associated with an increased risk of hepatic complications in the general populationMatthieu Wargny, Thomas Goronflot, Antoine Rimbert, et al.
Diabetes, Obesity & Metabolism|November 3, 2016
Glycaemic control influences the relationship between plasma PCSK9 and LDL cholesterol in type 1 diabetesStéphanie Laugier-Robiolle, Bruno Vergès, Maëlle Le Bras, et al.
Obesity (Silver Spring, Md.)|October 24, 2023
Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy improves lipid and glucose homeostasis in ob/ob miceSamuel Frey, Audrey Ayer, Thibaud Sotin, et al.
Thrombosis Research|September 4, 2017
Association of impaired renal function with venous thrombosis: A genetic risk score approachRomain Charmet, Astrid van Hylckama Vlieg, Marine Germain, et al.
Diabetologia|February 11, 2020
Serum tenascin-C is independently associated with increased major adverse cardiovascular events and death in individuals with type 2 diabetes: a French prospective cohortBarnabas Gellen, Nathalie Thorin-Trescases, Eric Thorin, et al.
Pageof 22

Showing results (101-110 of 216) with videos related to

Sort By:
Pageof 22
Journal of the American Heart Association|February 27, 2018
Circulating Concentrations of Redox Biomarkers Do Not Improve the Prediction of Adverse Cardiovascular Events in Patients With Type 2 Diabetes MellitusMaxime Cournot, Elena Burillo, Pierre-Jean Saulnier, et al.
International Journal of Cardiology|May 8, 2012
Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortalityRonan Roussel, Samy Hadjadj, Blandine Pasquet, et al.
Diabetes & Metabolism|October 22, 2020
Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO studyBertrand Cariou, Thomas Goronflot, Antoine Rimbert, et al.
Diabetes, Obesity & Metabolism|September 2, 2022
Associations of microvascular complications with all-cause death in patients with diabetes and COVID-19: The CORONADO, ABCD COVID-19 UK national audit and AMERICADO study groupsSamy Hadjadj, Pierre-Jean Saulnier, Yue Ruan, et al.
Diabetologia|October 22, 2015
Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetesSamy Hadjadj, Bertrand Cariou, Frederic Fumeron, et al.
Journal of Hepatology|February 8, 2024
Primary hypocholesterolemia is associated with an increased risk of hepatic complications in the general populationMatthieu Wargny, Thomas Goronflot, Antoine Rimbert, et al.
Diabetes, Obesity & Metabolism|November 3, 2016
Glycaemic control influences the relationship between plasma PCSK9 and LDL cholesterol in type 1 diabetesStéphanie Laugier-Robiolle, Bruno Vergès, Maëlle Le Bras, et al.
Obesity (Silver Spring, Md.)|October 24, 2023
Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy improves lipid and glucose homeostasis in ob/ob miceSamuel Frey, Audrey Ayer, Thibaud Sotin, et al.
Thrombosis Research|September 4, 2017
Association of impaired renal function with venous thrombosis: A genetic risk score approachRomain Charmet, Astrid van Hylckama Vlieg, Marine Germain, et al.
Diabetologia|February 11, 2020
Serum tenascin-C is independently associated with increased major adverse cardiovascular events and death in individuals with type 2 diabetes: a French prospective cohortBarnabas Gellen, Nathalie Thorin-Trescases, Eric Thorin, et al.
Pageof 22